← Back to Clinical Trials
Recruiting NCT06398093

NCT06398093 Developing and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06398093
Status Recruiting
Phase
Sponsor University of California, San Diego
Condition Type 2 Diabetes
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-07-15
Primary Completion 2024-08

Trial Parameters

Condition Type 2 Diabetes
Sponsor University of California, San Diego
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-07-15
Completion 2024-08
Interventions
Self-Compassion Tool Kit

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

There is a high prevalence of anxiety and depression in patients with Type 2 Diabetes (T2D). While past studies demonstrate the potential therapeutic effect of mindfulness-based interventions in patients with T2D, little is understood about the mode of delivery or quantity of the intervention necessary to experience benefits. This project aims to develop and implement a self-compassion tool kit based on the principles of mindfulness and meditation to better understand how self-compassion works to affect psychological health and wellbeing in patients with T2D. The investigators will study the impact of a self-compassion tool kit - including mindfulness meditation, exercise, journaling and sleep parameters - on T2D. Enhancing emotional well-being could complement current T2D treatments to facilitate improved quality of life.

Eligibility Criteria

Inclusion Criteria: * Has type 2 diabetes * Has a score above 2 on the T2D Distress Assessment Scale Exclusion Criteria: * Does not have type 2 diabetes * Has a score above 2 on the T2D Distress Assessment Scale * Cannot safely exercise * Cannot complete the requested tasks

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology